BINSA Act

This bill would add biotechnology to the list of technologies covered by federal rules that limit or require notice of U.S. investments in certain foreign countries of concern, such as China. Biotechnology would include research, development, manufacturing, or sale of drugs, biological products, and therapeutic compounds. The bill would also add licensing of a prohibited technology from a covered foreign person to the list of covered transactions. The Treasury Secretary would have one year to issue a rule defining biotechnology, which could not include agricultural biotechnology or basic academic research without direct drug or therapy uses. The Defense Secretary would have 60 days to report to Congress on whether U.S. investment in China's biotechnology sector affects national security.

Full text and official record on Congress.gov

Sponsors

• Pete Ricketts Republican sponsor
• 1 cosponsors